Literature DB >> 20591109

Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management.

Ashley J Vargas1, Randy Burd.   

Abstract

Quercetin is a unique dietary polyphenol because it can exert biphasic dose-responses on cells depending on its concentration. Cancer preventative effects of quercetin are observed at concentrations of approximately 1-40 microM and are likely mediated by quercetin's antioxidant properties. Pro-oxidant effects are present at cellular concentrations of 40-100 microM. However, at higher concentrations, many novel pathways in addition to ROS contribute to its effects. The potent bioactivity of quercetin has led to vigorous study of this compound and revealed numerous pathways that could interact synergistically to prevent or treat cancer. The effect of intake and concentration on emerging pathways and how they may interact are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20591109     DOI: 10.1111/j.1753-4887.2010.00301.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  39 in total

1.  Rosmarinic acid and siRNA combined therapy represses Hsp27 (HSPB1) expression and induces apoptosis in human glioma cells.

Authors:  Aslıhan Şengelen; Evren Önay-Uçar
Journal:  Cell Stress Chaperones       Date:  2018-04-07       Impact factor: 3.667

2.  Pretreatment with quercetin prevents changes in lymphocytes E-NTPDase/E-ADA activities and cytokines secretion in hyperlipidemic rats.

Authors:  Josiane B S Braun; Jader B Ruchel; Alessandra G Manzoni; Fátima H Abdalla; Emerson A Casalli; Lívia G Castilhos; Daniela F Passos; Daniela B R Leal
Journal:  Mol Cell Biochem       Date:  2017-11-29       Impact factor: 3.396

3.  Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells.

Authors:  Temesgen Samuel; Khalda Fadlalla; Lachundra Mosley; Venkat Katkoori; Timothy Turner; Upender Manne
Journal:  Anticancer Res       Date:  2012-01       Impact factor: 2.480

4.  Safety assessment of the dietary supplement OxyELITE™ Pro (New Formula) in inbred and outbred mouse strains.

Authors:  Isabelle R Miousse; Charles M Skinner; Haixia Lin; Laura E Ewing; Stanley D Kosanke; D Keith Williams; Bharathi Avula; Ikhlas A Khan; Mahmoud A ElSohly; Bill J Gurley; Igor Koturbash
Journal:  Food Chem Toxicol       Date:  2017-08-24       Impact factor: 6.023

5.  Does quercetin protect human red blood cell membranes against γ-irradiation?

Authors:  Halina Malgorzata Zbikowska; Adam Antosik; Magdalena Szejk; Michal Bijak; Alicja Klaudia Olejnik; Joanna Saluk; Paweł Nowak
Journal:  Redox Rep       Date:  2013-11-20       Impact factor: 4.412

6.  Biotinylated quercetin as an intrinsic photoaffinity proteomics probe for the identification of quercetin target proteins.

Authors:  Rongsheng E Wang; Clayton R Hunt; Jiawei Chen; John-Stephen Taylor
Journal:  Bioorg Med Chem       Date:  2011-07-13       Impact factor: 3.641

7.  Neuroprotective effect of quercetin against hydrogen peroxide-induced oxidative injury in P19 neurons.

Authors:  Maja Jazvinšćak Jembrek; Lidija Vuković; Jasmina Puhović; Julija Erhardt; Nada Oršolić
Journal:  J Mol Neurosci       Date:  2012-03-14       Impact factor: 3.444

Review 8.  Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence.

Authors:  Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

9.  Quercetin supplementation: insight into the potentially harmful outcomes of neurodegenerative prevention.

Authors:  Maja Jazvinšćak Jembrek; Ana Čipak Gašparović; Lidija Vuković; Josipa Vlainić; Neven Žarković; Nada Oršolić
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-17       Impact factor: 3.000

10.  DRAQ7 as an Alternative to MTT Assay for Measuring Viability of Glioma Cells Treated With Polyphenols.

Authors:  Harcharan Kaur Rooprai; Patrick Lawrence; Sholeh Keshavarz; Pooja Yashod; Richard W Gullan; Richard P Selway; Derek Davies
Journal:  Anticancer Res       Date:  2020-10       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.